603P Objective Computerized Cognitive Assessment in Men with Metastatic Castrate-Resistant Prostate Cancer (mcrpc) Randomly Receiving Darolutamide or Enzalutamide in the ODENZA Trial
Annals of oncology(2021)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined